Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNano Genomics Inc (BNGO) vs Celsius Holdings, Inc. (CELH) Price & Performance

BioNano Genomics IncTrade
Celsius Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

BioNano Genomics Inc vs Celsius Holdings, Inc. — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Celsius Holdings, Inc. trades at $27.58 (market cap $7.11B). The key difference: Celsius Holdings, Inc. is far larger — about 520.5× BioNano Genomics Inc's market cap. Which is the better fit depends on your goals.

BNGOCELH
Market Cap
$13.66M$7.11B
Sector
HealthConsumer Staples
52-Week High
$4.92$64.86
52-Week Low
$1.06$23.77
Enterprise Value
$16.26M$8.90B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNano Genomics Inc

BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.

The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.

Celsius Holdings, Inc.

CELH trades at $27.37, up 0.59% on the day, but its technical outlook is bearish with key support at $26. Revenue growth remains strong, reaching $2.52B in 2025, though net income margins have compressed to 4.24%. The company faces headwinds from a recent earnings miss and core brand weakness, but maintains a robust 95.65% analyst buy rating with a $44.08 consensus price target.

The stock offers significant upside potential based on analyst targets, but risks include execution challenges, intense competition, and margin pressure. Investor sentiment is cautious due to slowing growth and leadership changes, yet the long-term growth story, supported by the PepsiCo partnership, remains intact for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

Read more on BNGO

About Celsius Holdings, Inc.

Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.

Read more on CELH